Viemed Healthcare (VMD) Insider Smokoff Sells $230K of Stock

Timothy Smokoff recently sold 20,000 shares of VMD at an average price of $11.50 per share. This transaction, which occurred on June 24, 2026, was valued at approximately $229,968. Smokoff's sale was not part of a pre-planned trading program.

Other Institutional Activity in VMD

Several institutional investors have adjusted their positions in VMD. BlackRock, Inc. reduced its holdings slightly by 3,514 shares to a total of 4,622,562 shares, valued at about $42.57 million. Forager Capital Management added 40,000 shares, increasing its stake by 1.4% to 2,825,871 shares, worth around $26.03 million. Goldman Sachs Group Inc. decreased its position by 25,399 shares, a 1.8% reduction, leaving it with 1,421,634 shares valued at approximately $13.09 million. Vanguard Capital Management opened a new position, acquiring 1,303,384 shares valued at about $12.00 million. Ameriprise Financial Inc. increased its holdings by 75,506 shares, a 9.2% rise, to 898,319 shares worth around $8.27 million.

Viemed Healthcare, Inc. Stock Up 30.5%

Shares of VMD traded near $11.63 on Saturday. The company has seen various insider activities and institutional movements, reflecting ongoing interest in its stock. The recent insider sale and institutional adjustments provide a glimpse into the dynamics affecting VMD's market performance.

Insider Buying and Selling at Viemed Healthcare, Inc.

In addition to Timothy Smokoff's recent sale, William Frazier, the Chief Medical Officer, sold 10,000 shares on June 25, 2026, and bought the same amount on the same day at a price of $1.81. On March 20, 2026, Michael Moore, the President, sold 65,000 shares at an average price of $8.77.

Analysts Set New Price Targets

On May 7, 2024, Lake Street reiterated its buy rating for VMD, maintaining a price target of $15.00. This target reflects a positive outlook from analysts, who continue to see potential in the stock.

Bottom Line

Timothy Smokoff's recent sale of VMD shares adds to the ongoing insider and institutional activity around the stock. Investors often monitor such transactions to gauge the confidence of those closest to the company. It's important to remember that these insider trades are disclosed after the fact and may not reflect the current position or sentiment. As always, investors should consider multiple factors when evaluating a stock.